Provider Network Models
Expert articles and analysis related to provider network models.
AI Summary — Last 24 Hours
CMS is continuing to push provider networks toward mandatory, episode-based accountability, with expanded joint replacement model participation expected by 2028—raising the stakes for hospitals, ASCs, home health agencies, and post-acute partners to manage total cost, discharge pathways, and functional outcomes across orthopedic episodes (Home Health Care News). At the same time, the proposed 2027 OPPS/ASC payment update—2.4% before future offsets—signals tighter facility economics that could accelerate site-of-care shifts and make network design more contentious for ACOs and payers balancing access, leakage, and preferred-provider performance (HFMA). In Medicaid, Indiana’s planned GLP-1 coverage under the BALANCE model shows states testing targeted population-health investments within budget constraints, while CMS’s drug prior authorization proposals and MA fraud enforcement underscore a broader push to align utilization management, affordability, and program integrity across risk-bearing networks.
Related Articles
SUSTAIN 340B Act proposes major changes for hospitals and pharmacies
A bipartisan working group in Congress released a preliminary legislative draft that attempts to resolve some of the most disputed aspects of the 340B Drug Pricing Program. One noteworthy provision in...
340B Purchases Surge Past $100 Billion
Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013–19
Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013–19  Health Affairs
Senators introduce bipartisan 340B legislation - aha.org
Senators introduce bipartisan 340B legislation  aha.org
Prescription spending shifts to innovative drugs: 5 notes
Prescription spending shifts to innovative drugs: 5 notes  Becker's Hospital Review
CANN Responds to HRSA's Revised 340B Rebate Model Pilot
340B's Next Era: Why Hospitals Must Pair Compliance With Measurable Quality Outcomes
340B's Next Era: Why Hospitals Must Pair Compliance With Measurable Quality Outcomes  Pharmacy Times
340B's Next Era: Why Hospitals Must Pair Compliance With Measurable Quality Outcomes
Understanding CMS’s Proposed Rule Regarding Prior Authorization For Drugs
Cross-posted with permission from Health Affairs Forefront. [Original Post: Michael Anne Kyle, Rachel Sachs. “Understanding CMS’s Proposed Rule Regarding Prior Authorization For Drugs,” Health Affairs...